Healthcare Industry News:  chest tube 

Devices Surgery

 News Release - May 12, 2006

Surgical Patch Provides Break-Through in Lung Surgery

ROSKILDE, Denmark--(HSMN NewsFeed)--May 12, 2006--TachoSil®, a new surgical patch approved for bleeding control, has shown to be superior to standard treatment in lung surgery. A new study shows that use of the patch reduces air leaks and shortens the period of hospitalization.

Data from a new prospective randomized trial shows that TachoSil® reduces intraoperative alveolar air leakage after lobectomy or segmentectomy by 43% compared to standard treatment. 152 patients were included in the trial, and the results also suggest a positive effect on the hospitalization period by reducing the amount and duration of air leaks. Patients treated with TachoSil® had a mean time to discharge of 6.2 days, whereas patients treated with standard treatment spent 7.7 days in hospital on average.

The data will be presented May 12 2006 at the spring meeting of the European Society of Thoracic Surgeons (ESTS) in Cluj, Romania. According to lead investigator Dr. Udo Anegg, University Medical School, Graz, Austria, the results are highly significant.

"The study shows that we can half the amount of air leaking from the chest tubes after lung surgery, and this is the case both intra-operatively and in the days following surgery. These results have a high clinical importance and could have a large impact on future lung surgery," says Dr. Anegg.

Clinical implications

Dr. Anegg believes that the use of TachoSil® will prove to have major clinical implications.

"Reduction in air leaks will not only lead to shortened hospitalization periods, but will also provide quicker mobilization by an earlier removal of the chest tubes, thus decreasing postoperative morbidity such as pleural infections, pulmonary embolism, respiratory distress and pain associated with thoracic drainage. Consequently, the period of antibiotic schedules and other medication can be shortened which in turn results in lower hospital costs," says Dr. Anegg, and continues:

"These results are relevant for all types of open lung surgery causing alveolar air leaks, as the patch is very easy to apply."

TachoSil® is a new generation of surgical patches for haemostatic treatment. The patch is ready-to-use and overcomes some of the problems related to traditional liquid tissue sealants, which require preparation and mixing before use, may be washed away by diffuse bleeding, and - for some products - possess the potential risk of immune reaction to bovine components.

High resolution photos of the application of TachoSil® and TachoSil® used in surgery are available by contacting jmel@nycomed.com


Source: Nycomed

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.